TY - JOUR
T1 - Vestibular dysfunction in a Japanese patient with a mutation in the gene OPA1
AU - Mizutari, Kunio
AU - Matsunaga, Tatsuo
AU - Inoue, Yasuhiro
AU - Kaneko, Hiroki
AU - Yagi, Hirotaka
AU - Namba, Kazunori
AU - Shimizu, Satoko
AU - Kaga, Kimitaka
AU - Ogawa, Kaoru
PY - 2010/6/15
Y1 - 2010/6/15
N2 - OPA1 mutations are known to cause autosomal dominant optic atrophy (ADOA), and some types of OPA1 mutations also cause auditory neuropathy. In the present study, we evaluated the vestibular dysfunction that accompanied auditory neuropathy in a patient with an OPA1 mutation. A caloric test failed to elicit nystagmus or dizziness in either ear. Vestibular evoked myogenic potentials (VEMPs) in the right ear were characterized by a normal biphasic waveform. In contrast, no VEMPs were evoked in the left ear. Model building suggested that the OPA1 mutation, p.R445H, indirectly distorts the catalytic structure of the GTPase reaction center and decreases GTPase activity. The patient complained of instability while walking or moving but thought these symptoms were caused by visual dysfunction. This is the first report of a detailed evaluation of vestibular dysfunction in a patient with an OPA1 mutation. This case suggests that vestibular dysfunction may be involved in motor instability in patients with an OPA1 mutation, even when patients do not complain of vestibular symptoms. Based on this case, we suggest that vestibular evaluation should be performed in auditory neuropathy patients carrying an OPA1 mutation, even if the patients are free of symptoms of vestibular dysfunction.
AB - OPA1 mutations are known to cause autosomal dominant optic atrophy (ADOA), and some types of OPA1 mutations also cause auditory neuropathy. In the present study, we evaluated the vestibular dysfunction that accompanied auditory neuropathy in a patient with an OPA1 mutation. A caloric test failed to elicit nystagmus or dizziness in either ear. Vestibular evoked myogenic potentials (VEMPs) in the right ear were characterized by a normal biphasic waveform. In contrast, no VEMPs were evoked in the left ear. Model building suggested that the OPA1 mutation, p.R445H, indirectly distorts the catalytic structure of the GTPase reaction center and decreases GTPase activity. The patient complained of instability while walking or moving but thought these symptoms were caused by visual dysfunction. This is the first report of a detailed evaluation of vestibular dysfunction in a patient with an OPA1 mutation. This case suggests that vestibular dysfunction may be involved in motor instability in patients with an OPA1 mutation, even when patients do not complain of vestibular symptoms. Based on this case, we suggest that vestibular evaluation should be performed in auditory neuropathy patients carrying an OPA1 mutation, even if the patients are free of symptoms of vestibular dysfunction.
KW - Auditory neuropathy
KW - Caloric test
KW - OPA1
KW - OPA1 predicted structure
KW - Vestibular dysfunction
KW - Vestibular evoked myogenic potentials (VEMPs)
UR - http://www.scopus.com/inward/record.url?scp=77952100139&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77952100139&partnerID=8YFLogxK
U2 - 10.1016/j.jns.2010.03.014
DO - 10.1016/j.jns.2010.03.014
M3 - Article
C2 - 20385391
AN - SCOPUS:77952100139
SN - 0022-510X
VL - 293
SP - 23
EP - 28
JO - Journal of the Neurological Sciences
JF - Journal of the Neurological Sciences
IS - 1-2
ER -